North America

Tue
29
Oct

The truth is, lots of athletes turn to weed to calm their nerves while taking to the field

 
Tue
29
Oct

New report suggests women are thriving in cannabis. Are they?

As a new industry, cannabis is often thought of as more egalitarian than more established ones. It tends to attract open-minded people, and cannabis companies can do business without as many traditions and conventions weighing them down. A new report from Marijuana Business Daily shows that this may be putting cannabis ahead of most industries in terms of women's representation.

Tue
29
Oct

How to get the most out of cannabis for chronic pain

Here are a few good ways to make sure that you’re getting the most out of nature’s finest medicine when dealing with chronic pain.

When you rely on medical marijuana to relieve chronic pain, you often need to dedicate your day to taking meds. This can lead to a tolerance issue that makes you feel like the effects of your weed have dulled, or that the dose isn’t enough to get you where you need to be in order to function.

Cancer patients, people living with nerve damage, back injuries and other types of chronic pain also run into this problem on the pharmaceutical side of things; the problem being that if you continue to increase your dosage of narcotic pain killers, they simply become killers. But this is not the case with cannabis.

Tue
29
Oct

Global CBD market expected to grow by 40 percent this year

CBD is the new sliced bread, toilet paper on rolls, and bottled spring water. And we can expect to see more traditional business sectors getting into CBD in the near future.

If the non-intoxicating marijuana compound cannabidiol (CBD) were a deadly virus sent to Earth by the Devil himself, it would be well on its way to rendering the global population extinct within the next few years.

Tue
29
Oct

Cannabis stocks: should you put your money in the pot?

While it may appear very enticing to jump in on the legalisation of cannabis by investing in the sector, leading reviewers are coming out strong against putting your money in cannabis stocks.

In the past several months, cannabis stocks have been taking a beating – the recent implosion of cannabis stocks has put many cannabis companies into red alert situations. Most are having extreme difficulty to raise any capital to keep the lights on.

Tue
29
Oct

What does it take to succeed in-house in the cannabis industry?

Recent reports predict that the global legal marijuana market will grow to 66.3 billion USD by 2025, with a compound annual growth rate of more than 25%. The cannabis industry is on the cusp of a revolution, and as the industry grows, so too will its appetite for seasoned and ambitious legal professionals.

Tue
29
Oct

The history of hybrids: How breeding and selection led to modern marijuana

Cannabis growers are always searching for the next remarkable strain. The countless flavors and multitude of effects combine to create endless possibilities. In the last 60 years, breeders have capitalized on the diversity of cannabis more than ever before, crossing strains from around the globe.

Tue
29
Oct

Medicinal cannabis not proven in mental health, study finds

Evidence is weak for whether medicinal cannabis treatments can relieve mental illnesses such as anxiety, depression and psychosis, and doctors should prescribe them with great caution, researchers said on Monday.

In a review of scientific studies that analyzed the impact of medicinal cannabinoids on six mental health disorders, the researchers found “a lack of evidence for their effectiveness.”

Their findings have important implications for countries such as the United States, Australia, Britain and Canada, where medical cannabis is being made available for patients with certain illness, said Louisa Degenhardt, a drug and alcohol expert at Australia’s University of New South Wales in Sydney.

Tue
29
Oct

CDC announces vape-related illnesses appear to be declining

It appears that the mysterious vaping-related illness sweeping the United States has started to slow down. On Friday, the Centers for Disease Control and Prevention announced that the casualty rate for the as-yet-unexplained health condition is “leveling off or even declining.”

The most recent victim count — calculated last Tuesday — stands at 1,604 individuals who have shown signs of the condition. 125 cases were diagnosed over the last week, and 34 people have died from the illness.

Mon
28
Oct

The 3 smartest ways to invest in marijuana stocks

Over the next decade, marijuana is projected to be one of the fastest growing industries. Having already more than tripled sales on a worldwide basis between 2014 and 2018 to $10.9 billion, the industry has some Wall Street forecasts calling for $50 billion, $75 billion, or even $200 billion in annual global weed sales by 2030. Figures like these are what make marijuana stocks such an attractive investment opportunity.

Pages

Subscribe to RSS - North America